Ad
related to: phases of clinical trials- Find a Location
Get Directions To The James
Locations in Central Ohio
- Find A Doctor
Browse The James Top Doctor By
Specialty, Cancer Type or Name
- Follow the Blog
Get The Latest News
And Updates from The James
- New Diagnostic Center
Same or Next Day Access to
Cancer Diagnostic Experts
- Find a Location
Search results
Eupraxia Pharmaceuticals Announces Expansion of RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment ...
NBC 10 - FOX 14 Monroe· 1 hour agoEupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology company leveraging its proprietary DiffuSphere™ technology ...
Biomica Presents Positive Clinical Data Update from Ongoing Phase 1 Trial of Microbiome-Based...
WTNH-TV New Haven· 7 hours agoData will be showcased at the 2024 American Society of Clinical Oncology (ASCO) annual meeting....
...Blueprint Medicines to Present the First Promising and Most Advanced Clinical Data for a CDK2...
WROC Rochester· 1 hour agoBlueprint Medicines Corporation (Nasdaq: BPMC) today announced updated data from the ongoing Phase 1 dose escalation portion of the VELA clinical ...
Invizius completes Phase I trial of dialysis priming product H-Guard
Clinical Trials Arena via Yahoo Finance· 10 hours agoIn a June 2023 announcement, Invizius said that the study enables them to stratify the patient...
EpicentRx Announces Oral Presentation for the Most Clinically Advanced TGF-β Ligand Trap, AdAPT-001,...
WROC Rochester· 1 hour agoClinical Oncology (ASCO) has invited Dr. Anthony P. Conley, an MD Anderson Cancer Center (MDACC) Sarcoma Specialist and Lead PI, to give an oral presentation on the unprecedented ...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 1 hour agoSNK02 has the potential to be a first-in-class cryopreserved allogeneic NK cell therapy for solid tumors that does not require lymphodepletion before administration, which may lead to better ...
Rigel Announces Presentations at the Upcoming 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress
WROC Rochester· 1 hour agoOral presentation of final five-year results from the registrational Phase 2 trial in R/R mIDH1 AML patients reinforces REZLIDHIA® (olutasidenib ...
Adlai Nortye starts subject dosing in Phase II rectal cancer trial
Clinical Trials Arena via Yahoo Finance· 10 hours agoAdlai Nortye has dosed the first subject in the Phase II ARTEMIS clinical trial of palupiprant...
Zai Lab doses first subject in Phase II plaque psoriasis treatment trial
Clinical Trials Arena via Yahoo Finance· 10 hours agoZai Lab has dosed the first subject in a Phase II clinical trial of ZL-1102, an investigational...
Sanofi reports positive data from Phase II asthma treatment trial
Clinical Trials Arena via Yahoo Finance· 10 hours agoSanofi has announced positive outcomes from a Phase II clinical trial of rilzabrutinib, an oral...